Background Hyperglycaemia has emerged as an important risk factor for death in
coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the association …

Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-
infections are rare. This can lead to increased complications, including antibacterial …

Background: During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …

It is unclear to which extent the higher mortality associated with hypertension in the
coronavirus disease (COVID-19) is due to its increased prevalence among older patients or …

Obesity is a chronic disease that leads to an increased risk of mortality and morbidity, and
the impact of the COVID-19 pandemic may create a new health challenge. There is clear …

La obesidad es una enfermedad crónica asociada a incremento de la morbimortalidad en el
mundo, y el impacto con la pandemia de COVID-19 puede suponer un nuevo reto sanitario …

(1) Background: Different clinical presentations in COVID-19 are described to date, from mild
to severe cases. This study aims to identify different clinical phenotypes in COVID-19 …

Background Identification of patients on admission to hospital with coronavirus infectious
disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been …

Abstract Objective Coronavirus disease 2019 (COVID-19) has a high incidence of intensive
care admittance due to the severe acute respiratory syndrome (SARS). Intensive care unit …

The high transmissibility of SARS-CoV-2 before and shortly after the onset of symptoms
suggests that only diagnosing and isolating symptomatic patients may not be sufficient to …